| Prev Close | 0.00 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 15.19 / 52.53 |
Momenta Pharmaceuticals, Inc. (MNTA)
0.00
NASDAQ
| Exchange | NASDAQ |
| Div & Yield | N.A. (N.A) |
The Nasdaq and Great Stock Picking Continue to Lead the Market Higher
If you're looking for some corrective action to gain momentum, then you will have to wait for broader selling.
Momenta Pharmaceuticals Could Finally Make a Big Upside Breakout
Let's review the charts and indicators.
The Stock Market Is on Autopilot
This market is badly in need of some resets as it has been nearly straight up the first week of the year.
Momenta Shares Down On Phase 1 Data for Biosimilar -- Biotech Movers
The Cambridge, Mass.-based company and Mylan said that M834, a proposed biosimilar of Orencia (abatacept), did not achieve its primary pharmacokinetic endpoints in a Phase 1 study.
Mylan Soars After FDA Approval for Generic Copaxone --Biotech Movers
The pharmaceutical company on Oct. 3 said the FDA has approved its generic version of Teva's multiple sclerosis drug Copaxone.
Prepare for Biotech Action Aplenty Today
As we await the jobs report, there is significant news across the biotech sector in the past 24 hours on some names I have mentioned in these pages. Amgen should be up nicely today after a judge stated that Regeneron would have to pull its PCKS9 inh...
Shark Bites: Energous, NeoPhotonics Top My Watch List
The market action is solid today as my hunt for individual stock picks continues.